BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 16103605)

  • 1. Efficacy of myrrh in the treatment of human Schistosomiasis mansoni.
    Barakat R; Elmorshedy H; Fenwick A
    Am J Trop Med Hyg; 2005 Aug; 73(2):365-7. PubMed ID: 16103605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.
    Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ
    Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and side effects of praziquantel in the treatment for Schistosoma mansoni infection in school children in Senbete Town, northeastern Ethiopia.
    Reta B; Erko B
    Trop Med Int Health; 2013 Nov; 18(11):1338-43. PubMed ID: 24103059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a combination of metrifonate and praziquantel in the treatment of Schistosoma mansoni infection in albino mice.
    Ebeid FA
    Arzneimittelforschung; 1995 Apr; 45(4):519-21. PubMed ID: 7779154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between infection intensity, serum immunoglobulin profile, cellular immunity and the efficacy of treatment with praziquantel in murine schistosomiasis mansoni.
    Nessim NG; Demerdash Z
    Arzneimittelforschung; 2000 Feb; 50(2):173-7. PubMed ID: 10719623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda.
    Tukahebwa EM; Vennervald BJ; Nuwaha F; Kabatereine NB; Magnussen P
    Trans R Soc Trop Med Hyg; 2013 Jun; 107(6):397-404. PubMed ID: 23596262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium.
    Taylor P; Murare HM; Manomano K
    J Trop Med Hyg; 1988 Feb; 91(1):13-7. PubMed ID: 3126306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection.
    Utzinger J; N'Goran EK; N'Dri A; Lengeler C; Tanner M
    Trop Med Int Health; 2000 Nov; 5(11):771-8. PubMed ID: 11123824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schistosoma mansoni eggs as a target for praziquantel: efficacy of oral application in mice.
    Giboda M; Smith JM
    J Trop Med Hyg; 1994 Apr; 97(2):98-102. PubMed ID: 8170010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
    Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
    Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of a Brazilian wild rodent isolate of Schistosoma mansoni to praziquantel in mice.
    Costa-Silva M; Barros Lde A; Garcia JS; Neves RH; Rodrigues-Silva R; Machado-Silva JR; Maldonado-Júnior A
    Exp Parasitol; 2012 Apr; 130(4):394-9. PubMed ID: 22343042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternate chemotherapy in experimental schistosomiasis.
    Ismail MM; Farghaly AM; Hassan MM; Youssef SM; Mohamed FE
    J Egypt Soc Parasitol; 1992 Aug; 22(2):321-6. PubMed ID: 1500769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schistosoma mansoni infection among preschool age children attending Erer Health Center, Ethiopia and the response rate to praziquantel.
    Kemal M; Tadesse G; Esmael A; Abay SM; Kebede T
    BMC Res Notes; 2019 Apr; 12(1):211. PubMed ID: 30953565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of praziquantel against Schistosoma mansoni-infections in Botswana.
    Friis H; Byskov J
    Trop Geogr Med; 1989 Jan; 41(1):49-51. PubMed ID: 2503911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Praziquantel side effects during treatment of Schistosoma mansoni infected pupils in Kibwezi, Kenya.
    Jaoko WG; Muchemi G; Oguya FO
    East Afr Med J; 1996 Aug; 73(8):499-501. PubMed ID: 8898462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of Schistosomiasis mansoni with a combination oxamniquine and praziquantel. II. Experimental observations during the patent phase].
    Campos R; Pinto PL; Amato Neto V; Moreira AA
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(3):111-4. PubMed ID: 2515575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosomiasis mansoni in Burundi: progress in its control since 1985.
    Engels D; Ndoricimpa J; Gryseels B
    Bull World Health Organ; 1993; 71(2):207-14. PubMed ID: 8490984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and side effects of praziquantel in the treatment of Schistosomiasis mansoni in schoolchildren in Shesha Kekele Elementary School, Wondo Genet, Southern Ethiopia.
    Erko B; Degarege A; Tadesse K; Mathiwos A; Legesse M
    Asian Pac J Trop Biomed; 2012 Mar; 2(3):235-9. PubMed ID: 23569905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals.
    Utzinger J; Chollet J; You J; Mei J; Tanner M; Xiao S
    Acta Trop; 2001 Sep; 80(1):9-18. PubMed ID: 11495639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali].
    Dabo A; Doucoure B; Koita O; Diallo M; Kouriba B; Klinkert MQ; Doumbia S; Doumbo O
    Med Trop (Mars); 2000; 60(4):351-5. PubMed ID: 11436587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.